In other news, on November 19, DexCom announced that the FDA cleared Dexcom Smart Basal, making it the first and only CGM-integrated basal insulin dosing optimizer for adults aged 18 and older with Type 2 diabetes. Specifically designed for patients using glargine U-100 long-acting insulin, this new tool simplifies the often difficult process of insulin initiation and management. The system uses data from the Dexcom G7 15 Day sensor and logged insulin doses to generate personalized daily recommendations. Th ...